Literature DB >> 7618437

Immunohistochemical study of calpain and its endogenous inhibitor in the skeletal muscle of muscular dystrophy.

T Kumamoto1, H Ueyama, S Watanabe, K Yoshioka, T Miike, D E Goll, M Ando, T Tsuda.   

Abstract

A calcium-dependent proteinase (calpain) has been suggested to play an important role in muscle degradation in Duchenne muscular dystrophy (DMD). In immunohistochemical studies, calpain and its endogenous inhibitor (calpastatin) were located exclusively in the cytoplasm in normal human muscles. The intensity of the staining was stronger in type 1 than in type 2 fibers. Quantitative immunohistochemical study showed an increase of calpain in biopsied muscles from the patients with DMD and Becker muscular dystrophy. Abnormal increases in calpain and calpastatin were demonstrated mainly in atrophic fibers, whereas necrotic fibers showed moderate or weak immunoreactions for the enzymes. Opaque fibers and hypertrophic fibers were negative. Not all dystrophin-deficient muscle fibers necessarily showed a strong reaction for calpain. We suggest that calpain may play an important role in muscle fiber degradation, especially in the early stage of muscle degradation in muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7618437     DOI: 10.1007/BF00307642

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  23 in total

1.  A calcium-activated neutral protease in normal and dystrophic human muscle.

Authors:  N C Kar; C M Pearson
Journal:  Clin Chim Acta       Date:  1976-12-01       Impact factor: 3.786

2.  Regulation of calcium concentration in voltage-clamped smooth muscle cells.

Authors:  P L Becker; J J Singer; J V Walsh; F S Fay
Journal:  Science       Date:  1989-04-14       Impact factor: 47.728

3.  Ca-activated neutral protease and its inhibitors: in vitro effect on intact myofibrils.

Authors:  H Sugita; S Ishiura; K Suzuki; K Imahori
Journal:  Muscle Nerve       Date:  1980 Jul-Aug       Impact factor: 3.217

4.  Calcium activated neutral proteases (milli- and micro-CANP) and endogenous CANP inhibitor of muscle in Duchenne muscular dystrophy (DMD).

Authors:  P A Reddy; T E Anandavalli; M P Anandaraj
Journal:  Clin Chim Acta       Date:  1986-11-15       Impact factor: 3.786

5.  Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin.

Authors:  P Y Fong; P R Turner; W F Denetclaw; R A Steinhardt
Journal:  Science       Date:  1990-11-02       Impact factor: 47.728

6.  Immunogold electron-microscopic localisation of calpain I in skeletal muscle of rats.

Authors:  N Yoshimura; T Murachi; R Heath; J Kay; B Jasani; G R Newman
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

7.  Localization of the Ca(2+)-dependent proteinases and their inhibitor in normal, fasted, and denervated rat skeletal muscle.

Authors:  T Kumamoto; W C Kleese; J Y Cong; D E Goll; P R Pierce; R E Allen
Journal:  Anat Rec       Date:  1992-01

8.  Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide.

Authors:  K Arahata; S Ishiura; T Ishiguro; T Tsukahara; Y Suhara; C Eguchi; T Ishihara; I Nonaka; E Ozawa; H Sugita
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

Review 9.  Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin?

Authors:  D E Goll; V F Thompson; R G Taylor; T Zalewska
Journal:  Bioessays       Date:  1992-08       Impact factor: 4.345

10.  Changes of myoplasmic calcium concentration during fatigue in single mouse muscle fibers.

Authors:  H Westerblad; D G Allen
Journal:  J Gen Physiol       Date:  1991-09       Impact factor: 4.086

View more
  9 in total

1.  Molecular adaptations of neuromuscular disease-associated proteins in response to eccentric exercise in human skeletal muscle.

Authors:  L Féasson; D Stockholm; D Freyssenet; I Richard; S Duguez; J S Beckmann; C Denis
Journal:  J Physiol       Date:  2002-08-15       Impact factor: 5.182

2.  Transforming growth factor betas are upregulated in the rat masseter muscle hypertrophied by clenbuterol, a beta2 adrenergic agonist.

Authors:  Satonari Akutsu; Akemi Shimada; Akira Yamane
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

3.  Peptidyl alpha-ketoamides with nucleobases, methylpiperazine, and dimethylaminoalkyl substituents as calpain inhibitors.

Authors:  Asli Ovat; Zhao Zhao Li; Christina Y Hampton; Seneshaw A Asress; Facundo M Fernández; Jonathan D Glass; James C Powers
Journal:  J Med Chem       Date:  2010-09-09       Impact factor: 7.446

Review 4.  The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states.

Authors:  P W Vanderklish; B A Bahr
Journal:  Int J Exp Pathol       Date:  2000-10       Impact factor: 1.925

5.  Poly A RNA status and expression of milli (m) and micro (μ) calpains in skeletal muscle of duchenne muscular dystrophy patients.

Authors:  Harleen Mangat; Tajamul Hussain; C Sundaram; Mp Js Anandaraj
Journal:  Indian J Clin Biochem       Date:  2002-07

6.  Analysis of calpain-3 protein in muscle biopsies of different muscular dystrophies from India.

Authors:  R Renjini; N Gayathri; A Nalini; M M Srinivas Bharath
Journal:  Indian J Med Res       Date:  2012-06       Impact factor: 2.375

Review 7.  Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy.

Authors:  Cara A Timpani; Alan Hayes; Emma Rybalka
Journal:  Orphanet J Rare Dis       Date:  2017-05-25       Impact factor: 4.123

8.  Effect of nutrient restriction and re-feeding on calpain family genes in skeletal muscle of channel catfish (Ictalurus punctatus).

Authors:  Elena Preziosa; Shikai Liu; Genciana Terova; Xiaoyu Gao; Hong Liu; Huseyin Kucuktas; Jeffery Terhune; Zhanjiang Liu
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

9.  Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice.

Authors:  F Duclos; V Straub; S A Moore; D P Venzke; R F Hrstka; R H Crosbie; M Durbeej; C S Lebakken; A J Ettinger; J van der Meulen; K H Holt; L E Lim; J R Sanes; B L Davidson; J A Faulkner; R Williamson; K P Campbell
Journal:  J Cell Biol       Date:  1998-09-21       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.